MSN Labs launches semaglutide

1 month ago 1

ARTICLE AD BOX

Semaglutide is the progressive constituent successful Danish large Novo Nordisk’s blockbuster diabetes and value nonaccomplishment drugs Wegovy and Ozempic

Published - April 17, 2026 10:36 p.m. IST - HYDERABAD

A handout representation shared by MSN Laboratories. | Photo Credit: Special arrangement

Drugmaker MSN Laboratories has launched its generic mentation of semaglutide nether Semabest marque successful the Indian market.

Priced astir 50% little than the innovator drug, the merchandise frankincense is bound to amended affordability and entree for patients. Semabest disposable arsenic a pre-filled pen for subcutaneous administration, the institution said announcing the motorboat pursuing Central Drugs Standard Control Organisation (CDSCO) approval.

Published - April 17, 2026 10:36 p.m. IST

Read Entire Article